Antiplatelet therapy: glycoprotein IIb/IIIa receptor antagonists |
| |
Authors: | Kessler S Kessler D Frishman W H |
| |
Affiliation: | Department of Medicine, New York Medical College, Valhalla 10595, USA. |
| |
Abstract: | The glycoprotein IIb/IIIa antagonists are potent drugs that inhibit platelet aggregation. They are formulated as monoclonal antibodies and synthetic peptides for intravenous use in patients undergoing high-risk angioplasty procedures and in patients with unstable coronary syndromes. Orally active agents are now being evaluated in clinical trials. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|